PSMA-PET Registry for Recurrent Prostate Cancer
common.study.values.description
“PSMA-PET Registry for Recurrent Prostate Cancer”
This study aims to institute a province-wide registry leveraging the availability of a new Positron Emission Tomography tracer, [18F]-DCFPyL and PET expertise across Ontario centers to improve our ability to characterize patterns of recurrence and personalize therapies in men with recurrent prostate cancer after primary treatment.
common.study.values.location
participant.ui.study.affiliations-map.online-study.header-virtual
participant.ui.study.affiliations-map.online-study.text
common.study.values.methods
common.study.methods.has-drugs-no
common.study.methods.is-healthy-yes
Diagnostic Test - [18F]-DCFPyL PET/ CT scan (PSMA PET)
Participants will undergo re-staging with [18F]-DCFPyL PET/CT Scan (PSMA PET).
participant.views.study.view.additional
participant.views.study.view.scientific-title
PSMA-PET Registry for Recurrent Prostate Cancer
common.study.values.clinical-trial-id
NCT03718260
participant.views.study.view.id
epYz6a
